Seeking Alpha

Medtronic Inc. (MDT)

  • Jun. 28, 2012, 10:21 AM
    More on the Supreme Court healthcare opinion: The court reinforces that individuals can simply refuse to comply with the mandate, and pay the tax. The Supreme Court's live blog is here.
  • Jun. 28, 2012, 10:13 AM
    More on the Supreme Court healthcare opinion: The bottom line: the entire ACA is upheld, with the exception that the federal government's power to terminate states' Medicaid funds is narrowly read. The Supreme Court's live blog is here.
    | Comment!
  • Jun. 28, 2012, 10:11 AM
    More on the Supreme Court healthcare opinion: The Medicaid provision is limited but not invalidated.
    | Comment!
  • Jun. 28, 2012, 10:10 AM
    The Supreme Court healthcare opinion: The individual mandate survives as a tax. You can read the full opinion here.
  • Jun. 27, 2012, 11:11 AM
    Medtronic (MDT +2%) says that a Virginia judge last week ruled that the company's stent grafts don't infringe a patent owned by W.L Gore. (PR)
    | Comment!
  • Jun. 21, 2012, 5:20 PM
    Medtronic (MDT) boosts its quarterly cash dividend by 7% to $0.26 per share. The company's dividend has more than doubled over the past five years, and today's announcement marks the company's 35th consecutive year of increased dividend payments.
  • Jun. 20, 2012, 9:56 AM
    Major medical device companies such as GE, Siemens (SI) and Medtronic (MDT) are developing cheaper equipment that can generate sales in emerging markets and maybe even in cost-cutting developed countries. Rather than making devices more complex and expensive, the idea behind this "frugal innovation" is to strip them down as much as possible.
  • May. 24, 2012, 4:11 PM
    China Kanghui Holdings (KH): Q1 EPS of $0.20 beats by $0.01. Revenue of $13.1M (+21.6% Y/Y) beats by $0.35M. (PR)
    | Comment!
  • May. 22, 2012, 7:50 AM
    Medtronic on (MDT) FQ4: Net profit rises to $991M from $776M, benefiting from growth across MDT's businesses and geographies - particularly in emerging markets - and strong product launches. Guidance: FY 2013 revenue growth 2%-4%, EPS of $3.62 to $3.70 vs. consensus of $3.66. Shares +2.65%.
    | Comment!
  • May. 22, 2012, 7:23 AM
    Medtronic (MDT): Q4 EPS of $0.99 beats by $0.01. Revenue of $4.3B (+3% Y/Y) beats by $70M. (PR)
  • May. 22, 2012, 12:05 AM
    Notable earnings before Tuesday’s open: AZO, BBY, MDT, RL, WSM
    | Comment!
  • May. 21, 2012, 5:30 PM
    Notable earnings before Tuesday’s open: AZO, BBY, MDT, RL, WSM
    | Comment!
  • May. 2, 2012, 10:40 AM
    Edwards Lifesciences (EW +0.9%) shrugs off this mornings weakness after the Centers for Medicare & Medical Services announced it will cover Transcatheter Aortic Valve Replacement procedures for the treatment of symptomatic aortic valve stenosis, for which EW's Sapien is a marquee product. Separately, Wells Fargo ups the shares to Outperform on the news.
    | Comment!
  • Apr. 30, 2012, 1:20 PM
    Medtronic (MDT +1.2%) gains after being upgraded to Buy on valuation earlier today at Lazard Capital, citing the company's new product growth potential.
    | Comment!
  • Apr. 9, 2012, 2:33 PM
    St. Jude Medical (STJ -4.8%) shares sink after calling attention to a medical journal article that shows Medtronic's (MDT -0.9%) heart device leads resulted in fewer deaths than its recalled Riata and Riata ST products. STJ says the article "substantially undercounted" deaths associated with MDT's Quattro Secure device and wants it retracted.
    | Comment!
  • Mar. 30, 2012, 4:35 PM
    Medtronic (MDT) says it's reached an agreement in principle to settle a previously disclosed federal securities class action filed against the company by the Minneapolis Firefighters Relief Association. Under the settlement, the company will make a payment of $85 million to resolve all of the class claims.
    | Comment!
MDT vs. ETF Alternatives
Company Description
Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in three operating segments that manufacture and sell device-based medical therapies.